Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Frequently asked questions
What sector does Stratec SE (SBS) operate in?
Stratec SE belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Stratec SE (SBS) current stock price?
As of the latest data, Stratec SE stock price is €23.95, with a previous close of €23.20. Stratec SE gained €0.75 in the last trading session, representing a 3.23% increase.
What is Stratec SE (SBS) current market capitalization?
Stratec SE market cap is approximately 291.13 million.
What is Stratec SE (SBS) Earnings Per Share (EPS)?
The trailing EPS is -€0.03, and the forward EPS is €1.74.
What is Stratec SE (SBS) EBITDA?
Stratec SE EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 10.15 million.
Does Stratec SE (SBS) pay dividends?
Yes. Stratec SE pays annual dividends with an annualized yield of 2.51% and an estimated annual payout of €0.60 per share.
When is the next ex-dividend date for Stratec SE (SBS)?
The next ex-dividend date is scheduled for June 24, 2027.
When is Stratec SE (SBS) next earnings report?
Stratec SE is expected to release its next earnings report on September 30, 2026.
What is Stratec SE (SBS) beta (volatility) score?
Stratec SE has a beta of 0.847, meaning its volatility is roughly in line with the market.
